Bridgeway Capital Management, LLC Axcella Health Inc. Transaction History

Bridgeway Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.16 - $1.1 $8,000 - $55,000	-50,000 Reduced 19.97%	200,409 $66,000
Q1 2022 May 16, 2022	BUY	$1.58 - $2.82 $126,400 - $225,600	80,000 Added 46.95%	250,409 $644,000
Q3 2021 Nov 15, 2021	BUY	$2.98 - $4.31 $96,677 - $139,825	32,442 Added 23.51%	170,409 $508,000
Q2 2021 Aug 16, 2021	SELL	$3.08 - $5.13 $75,460 - $125,685	-24,500 Reduced 15.08%	137,967 $553,000
Q1 2021 May 17, 2021	BUY	$4.55 - $6.72 $455,000 - $672,000	100,000 Added 160.08%	162,467 $773,000
Q4 2020 Feb 16, 2021	BUY	$4.24 - $5.97 $210,337 - $296,159	49,608 Added 385.78%	62,467 $324,000
Q2 2020 Aug 14, 2020	BUY	$2.94 - $7.7 $37,805 - $99,014	12,859 New	12,859 $71,000

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.